These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27566747)

  • 1. Contribution of the symptomatic lesion in establishing MS diagnosis and prognosis.
    Tintore M; Otero-Romero S; Río J; Arrambide G; Pujal B; Tur C; Galán I; Comabella M; Nos C; Arévalo MJ; Vidal-Jordana A; Castilló J; Rodríguez-Acevedo B; Midaglia L; Mitjana R; Auger C; Sastre-Garriga J; Rovira À; Montalban X
    Neurology; 2016 Sep; 87(13):1368-74. PubMed ID: 27566747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study.
    Filippi M; Preziosa P; Meani A; Ciccarelli O; Mesaros S; Rovira A; Frederiksen J; Enzinger C; Barkhof F; Gasperini C; Brownlee W; Drulovic J; Montalban X; Cramer SP; Pichler A; Hagens M; Ruggieri S; Martinelli V; Miszkiel K; Tintorè M; Comi G; Dekker I; Uitdehaag B; Dujmovic-Basuroski I; Rocca MA
    Lancet Neurol; 2018 Feb; 17(2):133-142. PubMed ID: 29275979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should the symptomatic region be included in dissemination in space in MRI criteria for MS?
    Brownlee WJ; Swanton JK; Miszkiel KA; Miller DH; Ciccarelli O
    Neurology; 2016 Aug; 87(7):680-3. PubMed ID: 27421541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor.
    Arrambide G; Rovira A; Sastre-Garriga J; Tur C; Castilló J; Río J; Vidal-Jordana A; Galán I; Rodríguez-Acevedo B; Midaglia L; Nos C; Mulero P; Arévalo MJ; Comabella M; Huerga E; Auger C; Montalban X; Tintore M
    Mult Scler; 2018 Mar; 24(3):301-312. PubMed ID: 28301287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion of clinically isolated syndrome to multiple sclerosis: a prospective study.
    Kolčava J; Kočica J; Hulová M; Dušek L; Horáková M; Keřkovský M; Stulík J; Dostál M; Kuhn M; Vlčková E; Bednařík J; Benešová Y
    Mult Scler Relat Disord; 2020 Sep; 44():102262. PubMed ID: 32570179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective combined brain and spinal cord MRI in clinically isolated syndromes and possible early multiple sclerosis: impact on dissemination in space and time.
    Jacobi C; Hähnel S; Martinez-Torres F; Rieger S; Jüttler E; Heiland S; Jarius S; Meyding-Lamadè U; Storch-Hagenlocher B; Wildemann B
    Eur J Neurol; 2008 Dec; 15(12):1359-64. PubMed ID: 19049554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS Study.
    Filippi M; Preziosa P; Meani A; Dalla Costa G; Mesaros S; Drulovic J; Ivanovic J; Rovira A; Tintorè M; Montalban X; Ciccarelli O; Brownlee W; Miszkiel K; Enzinger C; Khalil M; Barkhof F; Strijbis EMM; Frederiksen JL; Cramer SP; Fainardi E; Amato MP; Gasperini C; Ruggieri S; Martinelli V; Comi G; Rocca MA;
    Neurology; 2022 Jan; 98(1):e1-e14. PubMed ID: 34716250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes.
    Gaetani L; Prosperini L; Mancini A; Eusebi P; Cerri MC; Pozzilli C; Calabresi P; Sarchielli P; Di Filippo M
    J Neurol; 2018 Nov; 265(11):2684-2687. PubMed ID: 30196327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on clinically isolated syndrome.
    Thouvenot É
    Presse Med; 2015 Apr; 44(4 Pt 2):e121-36. PubMed ID: 25813099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinal cord lesions in patients with clinically isolated syndrome: a powerful tool in diagnosis and prognosis.
    Sombekke MH; Wattjes MP; Balk LJ; Nielsen JM; Vrenken H; Uitdehaag BM; Polman CH; Barkhof F
    Neurology; 2013 Jan; 80(1):69-75. PubMed ID: 23243070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High risk of early conversion to multiple sclerosis in clinically isolated syndromes with dissemination in space at baseline.
    Gaetani L; Fanelli F; Riccucci I; Eusebi P; Sarchielli P; Pozzilli C; Calabresi P; Prosperini L; Di Filippo M
    J Neurol Sci; 2017 Aug; 379():236-240. PubMed ID: 28716249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofilament light chain level is a weak risk factor for the development of MS.
    Arrambide G; Espejo C; Eixarch H; Villar LM; Alvarez-Cermeño JC; Picón C; Kuhle J; Disanto G; Kappos L; Sastre-Garriga J; Pareto D; Simon E; Comabella M; Río J; Nos C; Tur C; Castilló J; Vidal-Jordana A; Galán I; Arévalo MJ; Auger C; Rovira A; Montalban X; Tintore M
    Neurology; 2016 Sep; 87(11):1076-84. PubMed ID: 27521440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion of optic nerve involvement in dissemination in space criteria for multiple sclerosis.
    Brownlee WJ; Miszkiel KA; Tur C; Barkhof F; Miller DH; Ciccarelli O
    Neurology; 2018 Sep; 91(12):e1130-e1134. PubMed ID: 30120132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periventricular lesions and MS diagnostic criteria in young adults with typical clinically isolated syndromes.
    Brownlee WJ; Miszkiel KA; Altmann DR; Ciccarelli O; Miller DH
    Mult Scler; 2017 Jun; 23(7):1031-1034. PubMed ID: 27600111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive solitary sclerosis: Gradual motor impairment from a single CNS demyelinating lesion.
    Keegan BM; Kaufmann TJ; Weinshenker BG; Kantarci OH; Schmalstieg WF; Paz Soldan MM; Flanagan EP
    Neurology; 2016 Oct; 87(16):1713-1719. PubMed ID: 27638926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining high, medium and low impact prognostic factors for developing multiple sclerosis.
    Tintore M; Rovira À; Río J; Otero-Romero S; Arrambide G; Tur C; Comabella M; Nos C; Arévalo MJ; Negrotto L; Galán I; Vidal-Jordana A; Castilló J; Palavra F; Simon E; Mitjana R; Auger C; Sastre-Garriga J; Montalban X
    Brain; 2015 Jul; 138(Pt 7):1863-74. PubMed ID: 25902415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical isolated syndrome: a 3-year follow-up study in China.
    Liu Y; Duan Y; Yu C; Qin W; Chen H; Dong H; Ye J; Butzkueven H; Li K
    Clin Neurol Neurosurg; 2011 Oct; 113(8):658-60. PubMed ID: 21680087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application and a proposed modification of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromes.
    Kang H; Metz LM; Traboulsee AL; Eliasziw M; Zhao GJ; Cheng Y; Zhao Y; Li DK;
    Mult Scler; 2014 Apr; 20(4):458-63. PubMed ID: 23970502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and magnetic resonance imaging features of children, adolescents, and adults with a clinically isolated syndrome.
    Milos RI; Szimacsek M; Leutmezer F; Rostasy K; Blaschek A; Karenfort M; Schimmel M; Pritsch M; Storm Van's Gravesande K; Weber M; Schmoeger M; Seidl R; Prayer D; Kornek B
    Eur J Paediatr Neurol; 2018 Nov; 22(6):1087-1094. PubMed ID: 30195407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of sagittal short T1 inversion recovery and T2-weighted FSE sequences for detection of multiple sclerosis spinal cord lesions.
    Nayak NB; Salah R; Huang JC; Hathout GM
    Acta Neurol Scand; 2014 Mar; 129(3):198-203. PubMed ID: 23980614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.